Submit Deal

Submit Deal

Cover Image Christopher Whitmore

Christopher Whitmore

CFO at IMMUNE-ONC THERAPEUTICS

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 109 M

Avg. Deal Size£ 109 M

Market Context

Sort

05 Jan 2023|United States|Biotechnology

Target: IMMUNE-ONC THERAPEUTICS

Bidder: WUXI BIOLOGICS

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 108 M

Value

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite